Stage III thymoma: Relationship of local invasion to recurrence

Slides:

Advertisements

Similar presentations

Lost in translation The Journal of Thoracic and Cardiovascular Surgery

Advertisements

Manuel J. Antunes, MD, PhD, DSc

Stephen R. Broderick, MD, MPHS

Is lung cancer resection indicated in patients with idiopathic pulmonary fibrosis? Atsushi Watanabe, MD, PhD, Tetsuya Higami, MD, PhD, Syunsuke Ohori,

The eighth edition TNM stage classification for lung cancer: What does it mean on main street? Frank C. Detterbeck, MD The Journal of Thoracic and Cardiovascular.

One in every 14 patients with early-stage lung cancer is not being treated! Benny Weksler, MD, MBA The Journal of Thoracic and Cardiovascular Surgery

It is not just about surgery versus stereotactic ablative radiotherapy, it is about curing as many patients with lung cancer as possible Alessandro Brunelli,

“Lead from the front”: Participative leadership

Impact of tumor size on outcomes after anatomic lung resection for stage 1A non–small cell lung cancer based on the current staging system Shamus R.

Yesterday's heroic measure is now standard procedure: Extracorporeal membrane oxygenation as a bridge to lung transplant Victor van Berkel, MD, PhD

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Ultrasound, endoscopy, and the recurrent nerve

Outcomes of unexpected pathologic N1 and N2 disease after video-assisted thoracic surgery lobectomy for clinical stage I non–small cell lung cancer Hong.

Ground glass opacity of the lung: The veil that needs lifting

Intrinsic cardiac stem cells are essential for regeneration

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Extracorporeal membrane oxygenation with direct central cannulation followed by delayed chest closure for graft dysfunction after lung transplantation:

Victor van Berkel, MD, PhD

William M. DeCampli, MD, PhD

Multilevel data analysis: What? Why? How?

How should we treat air leaks?

Go on-pump or off-pump in diabetic patients?

Optimal treatment strategy for type A acute aortic dissection with intramural hematoma Mitsumasa Hata, MD, PhD, Hiroaki Hata, MD, Akira Sezai, MD, Isamu.

Intratumoral Lymphatic Vessel Involvement is an Invasive Indicator of Completely Resected Pathologic Stage I Non-small Cell Lung Cancer Masahiko Harada,

The lord of the rings Antonio Miceli, MD, PhD

Esophagectomy versus endoscopic resection for patients with early-stage adenocarcinoma: Mercedes versus Tesla Toni Lerut, MD The Journal of Thoracic.

The variability of the mitral valve anatomy and terminology

Yang Zhang, MD, Haiquan Chen, MD, PhD

Aditya K. Kaza, MD The Journal of Thoracic and Cardiovascular Surgery

Juan N. Pulido, MD The Journal of Thoracic and Cardiovascular Surgery

Impact of positive pleural lavage cytology on survival in patients having lung resection for non–small-cell lung cancer: An international individual patient.

Innovation and science: The future of valve design

The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery Vinay Badhwar, MD The Journal of Thoracic and.

It's not “just a shunt” but sometimes it should be…

Fixing the supply problem

Results of surgical intervention for p-stage IIIA (N2) non–small cell lung cancer: Acceptable prognosis predicted by complete resection in patients with.

Military surgeons just want to have fun

A first start for lung transplantation?

Stephen R. Broderick, MD, MPHS

Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD

Yusuke Takahashi, MD, PhD, Prasad S. Adusumilli, MD

Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD

Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD

Niv Ad, MD, Lawrence M. Wei, MD

Attachment disorder in thoracoabdominal surgery

Uma M. Sachdeva, MD, PhD, Daniela Molena, MD

Video-assisted resection for lung cancer results in fewer complications Lunxu Liu, PhD, MD, FRCS The Journal of Thoracic and Cardiovascular Surgery

Passing the torch The Journal of Thoracic and Cardiovascular Surgery

Prognosis and “granularity”: Building on staging foundations?

Innovation in cardiothoracic surgical training

The origins of open heart surgery at the University of Minnesota 1951 to 1956 Richard A. DeWall, MD The Journal of Thoracic and Cardiovascular Surgery

Bryan M. Burt, MD The Journal of Thoracic and Cardiovascular Surgery

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The Journal of Thoracic and Cardiovascular Surgery

Discussion The Journal of Thoracic and Cardiovascular Surgery

Tissue valve, nitinol stent, or storage solution

The future of cardiac surgery training: A survival guide

The continuing challenge of congenital heart disease in China

Between a rock and a hard place

Prognosis of patients undergoing emergency surgery for type A acute aortic dissection without exclusion of the intimal tear Satoshi Unosawa, MD, PhD,

“The more things change…”: The challenges ahead

Why arch curvature affects arch resistance

Aritoshi Hattori, MD, Kenji Suzuki, MD

Preoperative PFTs: The answer is blowing in the wind

Sunjay Kaushal, MD, PhD, Brody Wehman, MD

Did you like Terminator 3 better than Terminator 2

Samuel Kim, MD The Journal of Thoracic and Cardiovascular Surgery

How do we follow up our patients

Journal changes and initiatives

Deciding how much to pay for effective care

Presentation transcript:

Stage III thymoma: Relationship of local invasion to recurrence Tomoki Utsumi, MD, PhD, Hiroyuki Shiono, MD, PhD, Akihide Matsumura, MD, PhD, Hajime Maeda, MD, PhD, Mitsunori Ohta, MD, PhD, Hirohito Tada, MD, PhD, Akinori Akashi, MD, PhD, Meinoshin Okumura, MD, PhD The Journal of Thoracic and Cardiovascular Surgery Volume 136, Issue 6, Pages 1481-1485 (December 2008) DOI: 10.1016/j.jtcvs.2008.05.012 Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Actuarial survival curves of patients with involvement of the great vessels (A), lung (B), and pericardium (C), as well as for all patients (D). In each panel, + indicates cases with involvement of the specified organ, − indicates those without involvement, and + or − indicates those with and without such involvement. V, Great vessels; L, lung; P, pericardium. The Journal of Thoracic and Cardiovascular Surgery 2008 136, 1481-1485DOI: (10.1016/j.jtcvs.2008.05.012) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Actuarial survival curves of patients with WHO cell types B1, B2, and B3. The Journal of Thoracic and Cardiovascular Surgery 2008 136, 1481-1485DOI: (10.1016/j.jtcvs.2008.05.012) Copyright © 2008 The American Association for Thoracic Surgery Terms and Conditions